Patents by Inventor Dennis Bryan Zerby

Dennis Bryan Zerby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20210163476
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 16, 2021
    Publication date: June 3, 2021
    Inventors: David Michael SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid Warren VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    Patent number: 10934284
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: March 2, 2021
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. Von Borstel, Rui Li, Julian Reading, Stephen Wolpe
  • AMINOQUINAZOLINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20190194193
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 27, 2019
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
    Publication number: 20180298000
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE, Nureddin AMAN
  • Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    Patent number: 10030015
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: July 24, 2018
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20150361077
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming LU, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • Nucleic acids encoding estrogen receptor ligand binding domain variants
    Patent number: 7381813
    Abstract: Mutants of steroid receptor ligand binding domains and synthetic ligands which have specific binding affinities for these receptors are provided. The use of these LBD-ligand combinations for construction of selective “molecular gene switches” is disclosed. Methods of regulating gene function using these switches are provided.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: June 3, 2008
    Assignee: Novartis AG
    Inventors: Kathryn Rene Bracken, Joseph Ernest de los Angeles, Ying Huang, Michael Joseph Kadan, Gary Michael Ksander, Dennis Bryan Zerby
  • Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
    Publication number: 20030143559
    Abstract: Mutants of steroid receptor ligand binding domains and synthetic ligands which have specific binding affinities for these receptors are provided. The use of these LBD-ligand combinations for construction of selective “molecular gene switches” is disclosed. Methods of regulating gene function using these switches are provided.
    Type: Application
    Filed: May 31, 2002
    Publication date: July 31, 2003
    Inventors: Kathryn Rene Bracken, Joseph Ernest de los Angeles, Ying Huang, Michael Joseph Kadan, Gary Michael Ksander, Dennis Bryan Zerby